XM does not provide services to residents of the United States of America.

CDC confirms human case of bird flu in Missouri



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-CDC confirms human case of bird flu in Missouri</title></head><body>

Adds details and background throughout

Sept 6 (Reuters) -The U.S. Centers for Disease Control and Prevention on Friday confirmed a human case of avian influenza A reported by the state of Missouri.

The case was identified through that state's seasonal flu surveillance system, the agency said.

The case was confirmed on Thursday, the CDC said, adding that an investigation into the potential exposure is ongoing by the Missouri Department of Health and Senior Services.

The patient, who was hospitalized, had underlying medical conditions and was treated with influenza antiviral medications. The patient was subsequently discharged and has recovered.

There is no immediate known animal exposure and no ongoing transmission among close contacts or otherwise has been identified.

This is the 14th human case of H5 reported in the United States during 2024 and the first case of H5 without a known occupational exposure to sick or infected animals.

While other novel flu cases have been detected through the country's national flu surveillance system, this is the first time that system has detected a case of H5, the CDC said.

H5 bird flu is widespread in wild birds worldwide and is causing outbreaks in poultry and U.S. dairy cows, with several recent human cases in U.S. dairy and poultry workers.

While, outbreaks of H5 have been reported in commercial and backyard poultry flocks in 2024, outbreaks in cattle have not been reported in Missouri.

Missouri's last reported case of bird flu in a commercial poultry flock was in February, according to USDA.

H5N1 bird flu has been detected in wild birds in the state in the past.

Fourteen U.S. states have reported an outbreak of the H5N1 virus in dairy cattle.

The virus's jump to cows from birds has heightened concerns it could adapt to spread among humans.

The CDC said the risk to the general public from H5N1 remains low, based on available data.



Reporting by Sriparna Roy in Bengaluru; Editing by Maju Samuel

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.